| CXCL10 is critical for the progression and maintenance of depigmentation in a mouse model of vitiligo M Rashighi, P Agarwal, JM Richmond, TH Harris, K Dresser, MW Su, ... Science translational medicine 6 (223), 223ra23-223ra23, 2014 | 496 | 2014 |
| Vitiligo pathogenesis and emerging treatments M Rashighi, JE Harris Dermatologic clinics 35 (2), 257-265, 2017 | 264 | 2017 |
| Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA) JE Harris, M Rashighi, N Nguyen, A Jabbari, G Ulerio, R Clynes, ... Journal of the American Academy of Dermatology 74 (2), 370-371, 2016 | 225 | 2016 |
| A network of high-mobility group box transcription factors programs innate interleukin-17 production N Malhotra, K Narayan, OH Cho, KE Sylvia, C Yin, H Melichar, ... Immunity 38 (4), 681-693, 2013 | 184 | 2013 |
| Interfering with the IFN-γ/CXCL10 pathway to develop new targeted treatments for vitiligo M Rashighi, JE Harris Annals of translational medicine 3 (21), 2015 | 151 | 2015 |
| What patients with vitiligo believe about their condition A Firooz, N Bouzari, N Fallah, B Ghazisaidi, MR Firoozabadi, Y Dowlati International journal of dermatology 43 (11), 811-814, 2004 | 151 | 2004 |
| Imiquimod in combination with meglumine antimoniate for cutaneous leishmaniasis: a randomized assessor-blind controlled trial A Firooz, A Khamesipour, MH Ghoorchi, M Nassiri-Kashani, SE Eskandari, ... Archives of dermatology 142 (12), 1575-1579, 2006 | 137 | 2006 |
| Resident memory and recirculating memory T cells cooperate to maintain disease in a mouse model of vitiligo JM Richmond, JP Strassner, M Rashighi, P Agarwal, M Garg, KI Essien, ... Journal of Investigative Dermatology 139 (4), 769-778, 2019 | 131 | 2019 |
| Striae gravidarum: associated factors A Ghasemi, F Gorouhi, M Rashighi‐Firoozabadi, S Jafarian, A Firooz Journal of the European Academy of Dermatology and Venereology 21 (6), 743-746, 2007 | 126 | 2007 |
| Understanding autoimmunity of vitiligo and alopecia areata JF Rork, M Rashighi, JE Harris Current opinion in pediatrics 28 (4), 463-469, 2016 | 122 | 2016 |
| Simvastatin prevents and reverses depigmentation in a mouse model of vitiligo P Agarwal, M Rashighi, KI Essien, JM Richmond, L Randall, ... Journal of Investigative Dermatology 135 (4), 1080-1088, 2015 | 114 | 2015 |
| Suction blistering the lesional skin of vitiligo patients reveals useful biomarkers of disease activity JP Strassner, M Rashighi, MA Refat, JM Richmond, JE Harris Journal of the American Academy of Dermatology 76 (5), 847-855. e5, 2017 | 109 | 2017 |
| Concepts of patients with alopecia areata about their disease A Firooz, MR Firoozabadi, B Ghazisaidi, Y Dowlati BMC dermatology 5, 1-5, 2005 | 89 | 2005 |
| The impact of telehealth implementation on underserved populations and no-show rates by medical specialty during the COVID-19 pandemic EB Franciosi, AJ Tan, B Kassamali, N Leonard, G Zhou, S Krueger, ... Telemedicine and e-Health 27 (8), 874-880, 2021 | 76 | 2021 |
| Comparison of long-pulsed alexandrite and Nd: YAG lasers, individually and in combination, for leg hair reduction: an assessor-blinded, randomized trial with 18 months of follow-up SM Davoudi, F Behnia, F Gorouhi, S Keshavarz, MN Kashani, ... Archives of dermatology 144 (10), 1323-1327, 2008 | 71 | 2008 |
| Pimecrolimus cream, 1%, vs hydrocortisone acetate cream, 1%, in the treatment of facial seborrheic dermatitis: a randomized, investigator-blind, clinical trial A Firooz, A Solhpour, F Gorouhi, M Daneshpazhooh, K Balighi, ... Archives of Dermatology 142 (8), 1065-1086, 2006 | 69 | 2006 |
| 乳鼠心肌提取 HHS Public Access M Rashighi, JE Harris Physiol Behav 176 (3), 139-148, 2017 | 66 | 2017 |
| Comparison of hydration, sebum and pH values in clinically normal skin of patients with atopic dermatitis and healthy controls A Firooz, F Gorouhi, P Davari, M Atarod, S Hekmat, ... Clinical and experimental dermatology 32 (3), 321-322, 2007 | 58 | 2007 |
| Rosacea fulminans (pyoderma faciale): successful treatment of a 3‐year‐old girl with oral isotretinoin A Firooz, MR Firoozabadi, Y Dowlati International journal of dermatology 40 (3), 203-205, 2001 | 45 | 2001 |
| Understanding the impact of teledermatology on no-show rates and health care accessibility: a retrospective chart review EB Franciosi, AJ Tan, B Kassamali, DM O'Connor, M Rashighi, ... Journal of the American Academy of Dermatology 84 (3), 769-771, 2021 | 42 | 2021 |
